Literature DB >> 19476953

The pathology and pathogenesis of bluetongue.

N J Maclachlan1, C P Drew, K E Darpel, G Worwa.   

Abstract

Bluetongue (BT) is an insect-transmitted viral disease of wild and domestic ruminants and, occasionally, other species. Amongst domestic livestock, BT is most common in certain breeds of sheep whereas asymptomatic BT virus (BTV) infection of cattle is typical in enzootic regions. BT in cattle can be a feature of specific outbreaks, notably the current epizootic in Europe caused by BTV serotype 8. BTV replicates within mononuclear phagocytic and endothelial cells, lymphocytes and possibly other cell types in lymphoid tissues, the lungs, skin and other tissues. Infected ruminants may exhibit a prolonged but not persistent viraemia and BTV is associated with erythrocytes during the late stages of this prolonged viraemia. The pathogenesis of BT involves injury to small blood vessels in target tissues, but the relative contributions of direct virus-induced cytolysis and virus-induced vasoactive mediators in causing endothelial injury and dysfunction are presently unclear. The lesions of BT are characteristic and include: haemorrhage and ulcers in the oral cavity and upper gastrointestinal tract; necrosis of skeletal and cardiac muscle; coronitis; subintimal haemorrhage in the pulmonary artery; oedema of the lungs, ventral subcutis, and fascia of the muscles of the neck and abdominal wall; and pericardial, pleural and abdominal effusions. Transplacental transmission of BTV in ruminants, with subsequent fetal infection, is a property of specific virus strains, especially those propagated in embryonated eggs or cell culture. The outcome of BTV infection of fetal ruminants is age-dependent, with distinctive cavitating lesions of the central nervous system in animals that survive infection in early gestation. Immune competence to BTV arises by mid-gestation, and animals infected in late gestation can be born viraemic and without significant brain malformations.

Entities:  

Mesh:

Year:  2009        PMID: 19476953     DOI: 10.1016/j.jcpa.2009.04.003

Source DB:  PubMed          Journal:  J Comp Pathol        ISSN: 0021-9975            Impact factor:   1.311


  123 in total

1.  The genome sequence of bluetongue virus type 10 from India: evidence for circulation of a western topotype vaccine strain.

Authors:  Sushila Maan; Narender S Maan; Gillian Pullinger; Kyriaki Nomikou; Elizabeth Morecroft; Marc Guimera; Manjunatha N Belaganahalli; Peter P C Mertens
Journal:  J Virol       Date:  2012-05       Impact factor: 5.103

2.  Bluetongue virus infection activates bovine monocyte-derived macrophages and pulmonary artery endothelial cells.

Authors:  Clifton P Drew; Meera C Heller; Christie Mayo; Joie L Watson; N James Maclachlan
Journal:  Vet Immunol Immunopathol       Date:  2010-03-10       Impact factor: 2.046

3.  Bluetongue virus infection alters the impedance of monolayers of bovine endothelial cells as a result of cell death.

Authors:  Clifton P Drew; Ian A Gardner; Christie E Mayo; Eiko Matsuo; Polly Roy; N James MacLachlan
Journal:  Vet Immunol Immunopathol       Date:  2010-03-10       Impact factor: 2.046

4.  Interference of vaccination against bluetongue virus serotypes 1 and 8 with serological diagnosis of small-ruminant lentivirus infection.

Authors:  Stephen Valas; Alain Le Ven; Benoit Croise; Maud Maquigneau; Cécile Perrin
Journal:  Clin Vaccine Immunol       Date:  2011-01-12

5.  A protective bivalent vaccine against Rift Valley fever and bluetongue.

Authors:  Eva Calvo-Pinilla; Alejandro Marín-López; Sandra Moreno; Gema Lorenzo; Sergio Utrilla-Trigo; Luis Jiménez-Cabello; Julio Benavides; Aitor Nogales; Rafael Blasco; Alejandro Brun; Javier Ortego
Journal:  NPJ Vaccines       Date:  2020-07-30       Impact factor: 7.344

6.  Real-time quantitative reverse transcription-PCR assays specifically detecting bluetongue virus serotypes 1, 6, and 8.

Authors:  Bernd Hoffmann; Michael Eschbaumer; Martin Beer
Journal:  J Clin Microbiol       Date:  2009-07-15       Impact factor: 5.948

7.  Full genome characterisation of bluetongue virus serotype 6 from the Netherlands 2008 and comparison to other field and vaccine strains.

Authors:  Sushila Maan; Narender S Maan; Piet A van Rijn; René G P van Gennip; Anna Sanders; Isabel M Wright; Carrie Batten; Bernd Hoffmann; Michael Eschbaumer; Chris A L Oura; Abraham C Potgieter; Kyriaki Nomikou; Peter P C Mertens
Journal:  PLoS One       Date:  2010-04-23       Impact factor: 3.240

8.  A clathrin independent macropinocytosis-like entry mechanism used by bluetongue virus-1 during infection of BHK cells.

Authors:  Sarah Gold; Paul Monaghan; Peter Mertens; Terry Jackson
Journal:  PLoS One       Date:  2010-06-29       Impact factor: 3.240

Review 9.  Re-emergence of bluetongue, African horse sickness, and other orbivirus diseases.

Authors:  N James Maclachlan; Alan J Guthrie
Journal:  Vet Res       Date:  2010-01-27       Impact factor: 3.683

10.  RT-PCR assays for seven serotypes of epizootic haemorrhagic disease virus & their use to type strains from the Mediterranean region and North America.

Authors:  Narender S Maan; Sushila Maan; Kyriaki Nomikou; Donna J Johnson; Mehdi El Harrak; Hafsa Madani; Hagai Yadin; Serife Incoglu; Kadir Yesilbag; Andrew B Allison; David E Stallknecht; Carrie Batten; Simon J Anthony; Peter P C Mertens
Journal:  PLoS One       Date:  2010-09-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.